Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
About this item
Full title
Author / Creator
Publisher
Ankara: Galenos Publishing House
Journal title
Language
Formats
Publication information
Publisher
Ankara: Galenos Publishing House
Subjects
More information
Scope and Contents
Contents
SummaryIntroduction: The Coronavirus disease-2019 (COVID-19) pandemic that started over two years ago has led to high mortality and morbidity. Vaccine studies have been initiated worldwide to end the pandemic, and the CoronaVac® vaccine was first administered to healthcare workers at high risk of COVID-19 in Turkey. In our study, we aimed to invest...
Alternative Titles
Full title
Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e4d05add35bd458da93a2020a64fcbf0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4d05add35bd458da93a2020a64fcbf0
Other Identifiers
ISSN
2147-673X
E-ISSN
2147-673X
DOI
10.4274/mjima.galenos.2022.2021.24
